Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022
THIS has been a remarkable year for European cannabis with some significant milestones passed on an increasingly fruitful trek into
FURTHER evidence of pharmaceutical interest in the European cannabis space has emerged with German business Dermapharm Holding acquiring Canopy Growth
4C LABS has officially received a specialist clinic licence from the UK’s Care Quality Commission (CQC), enabling it to launch
CONSERVATIVE MPs have blocked efforts to boost UK medical cannabis access with the Government saying the existing legislation is sufficient.
 Apollon Formularies Plc (AQSE: APOL) (“Apollon” or the “Company”), a UK based international medical cannabis pharmaceutical company trading on Aquis Stock Exchange, is
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over
ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy and
MGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away
Biotech start-up Overseed has been awarded the first licence for agronomic and genetic research on cannabis in France by the
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
